CBUS
CBUS
US17166A1016
Cibus, Inc.
Loading chart...

Company Profile

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Latest News

Related stocks

CBIO
CBIO • United States
Crescent Biopharma, Inc.
14.91 USD
553.86M USD 1Y +17.1%
MNPR
MNPR • United States
Monopar Therapeutics Inc.
78.96 USD
529.99M USD 1Y -14.8%
CRMD
CRMD • United States
CorMedix Inc.
7.38 USD
575.23M USD 1Y -35%
SGP
SGP • United States
SpyGlass Pharma, Inc.
24.92 USD
833.52M USD
DSGN
DSGN • United States
Design Therapeutics, Inc.
11.65 USD
729.08M USD 1Y +65.6%
JBIO
JBIO • United States
Jade Biosciences, Inc.
14.39 USD
915.17M USD 1Y +55.8%
ODTX
ODTX • United States
Odyssey Therapeutics, Inc.
19 USD
913.11M USD
PBYI
PBYI • United States
Puma Biotechnology Inc
10.29 USD
531.17M USD 1Y +90.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
115.6% p.a.
Max Drawdown (5Y)
-99.4%
Sharpe Ratio (5Y)
-0.54
Beta Factor
1.57
Size Class
Micro Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 1934%.
High market risk: Beta of 1.57 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (115.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.9% in the extended horizon.
ende